Inventor

WROBLESKI STEPHEN T

US48 patents

⚠️ This page may combine multiple inventors who share the name “WROBLESKI STEPHEN T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WROBLESKI STEPHEN T

BRISTOL MYERS SQUIBB CO

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Fused heterocyclic compounds useful as kinase modulators

Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Pyrazole-amine compounds useful as kinase inhibitors

Pyrazole-amide compounds useful as kinase inhibitors

Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors

Pyrazole-amine compounds useful as kinase inhibitors

Pyrrolo-triazine aniline compounds useful as kinase inhibitors

Pyrazole-amine compounds useful as kinase inhibitors

Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors

Sulfone pyridine alkyl amide-substituted heteroaryl compounds

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNα

Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors

Pyrazole-amine compounds useful as kinase inhibitors

Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Pyrrolo-triazine aniline compounds useful as kinase inhibitors

Pyrrolo-triazine aniline compounds useful as kinase inhibitors

Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors

Process for preparing pyrrolotriazine kinase inhibitors

Sulfone pyridine alkyl amide-substituted heteroaryl compounds

N-heterocyclic inhibitors of TNF-alpha expression

Heterobicyclic compounds useful as kinase inhibitors

Indole indane amide compounds useful as CB2 agonists and method

Heterocyclic amide compounds useful as kinase inhibitors

Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors

Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors

Tricyclic-heteroaryl compounds useful as kinase inhibitors

Sulfone pyridine alkyl amide-substituted heteroaryl compounds

Phenyl-substituted pyrimidine compounds useful as kinase inhibitors

Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Heteroaryl-substituted pyrrolo-triazine compounds useful as kinase inhibitors

Heterocyclic compounds useful as inhibitors of TNF

Method for preparing pyrrolotriazine compounds

Tricyclic heterocyclic compounds useful as inhibitors of TNF

WROBLESKI STEPHEN T

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

Heterocyclic amide compounds useful as kinase inhibitors

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

PHARMACOPEIA INC

N-heterocyclic inhibitors of TNF-α expression

N-heterocyclic inhibitors of TNF-α expression

PHARMACEOPEIA INC

N-heterocyclic inhibitors of TNF-α expression

DHAR T G MURALI

Heterobicyclic compounds useful as kinase inhibitors